Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-12-02-2001
Volume25
Issue 12

Bioterrorism Threat Shines Spotlight on Drug Manufacturing

Author(s):

Jill Wechsler

Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.

External Link - article-3397.pdf

Articles in this issue
Bioterrorism Threat Shines Spotlight on Drug Manufacturing
E-Sourcing: Internet Facilitates Flexible Collaboration
International Employment Survey 2001
Outsourcing Outlook
A Comprehensive Approach to Pharmaceutical Engineering Training
Pharmaceutical Physics Particle-Size Distribution, Part I: Representations of Particle Shape, Size, and Distribution

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 12th 2025

FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS

Feliza Mirasol
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 12th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 12th 2025

The Future of Pharma: Connected, Continuous, and Compliant

Mike Hennessy Jr.
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
August 12th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Chemical molecular formula hormone serotonin. Silhouette of a man head. Connected lines with dots background. | Image Credit: © JEGAS RA - stock.adobe.com
August 12th 2025

Zenara Secures First Generic Sertraline Approval from FDA, Plus Six Months of Market Exclusivity

Patrick Lavery
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 12th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery